Drugmakers' deal making will plow ahead despite antitrust scrutiny, analysts say
Big pharma goes shopping as "patent cliff" puts more than $225 billion in revenues at risk.
Source: marketwatch.com
Page 7 - Evaluate Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Evaluate Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Evaluate Pharma Today - Breaking & Trending Today
Global 3D Protein Structure Analysis Market 2023 to 2027:
Dublin, July 07, 2023 (GLOBE NEWSWIRE) -- The "3D Protein Structure Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,...
Source: globenewswire.com
Global 3D Protein Structure Analysis Market Report 2023: Increase in R&D in Drug Discovery and Development Fuels the Sector
/PRNewswire/ -- The "3D Protein Structure Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027" report has been added to...
Source: prnewswire.com
9 Highly Anticipated FDA Decisions in Second Half of 2023
After a series of milestone approvals in the first half of 2023, the FDA is slated to decide on four more firsts before the year’s end.
Source: biospace.com
Global Rare Disease Clinical Trials Market to 2030:
Dublin, June 09, 2023 (GLOBE NEWSWIRE) -- The "Rare Disease Clinical Trials Market Size, Share & Trends Analysis Report By Therapeutic Area...
Source: globenewswire.com